Research

Hormonal

Long-term metformin therapy (up to 10 years) in overweight-obese women with PCOS and normal baseline glucose homeostasis results in significant initial weight loss, stabilization of body mass, improved menstrual frequency, and reduced androgen levels, with a very low conversion rate to diabetes.

For overweight or obese women with PCOS who have normal blood sugar, metformin (up to 2000mg/day) can help with weight loss, menstrual regularity, and lowering male hormones. The biggest weight loss happens in the first year, after which weight stabilizes. It is generally well-tolerated, but sticking with it long-term is hard because the initial excitement fades. Consistent use helps maintain these benefits and prevents diabetes.

ModerateSupportsMEDIUM confidence
Long-term metformin treatment of overweight-obese women with PCOS and normal baseline glycemic homeostasis resulted in reduction and stabilization of BM, improvements of MF and androgen profile and low conversion rate to diabetes.
Mojca Jensterle et al. · Endocrine Connections · 2020

Why this rating

Retrospective cohort study with long follow-up but high dropout rates and lack of a placebo control group.

Source

Long-term efficacy of metformin in overweight-obese PCOS: longitudinal follow-up of retrospective cohort

Mojca Jensterle et al. · Endocrine Connections · 2020

DOI 10.1530/ec-19-0449

cohort · n=159Cited 48×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →